Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Architecture of autoinhibited and active BRAF-MEK1-14-3-3 complexes
Eunyoung Park1,2, Shaun Rawson2, Kunhua Li1,2
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract:
RAF family kinases are RAS-activated switches that initiate signalling through the MAP kinase cascade to control cellular proliferation, differentiation and survival1-3. RAF activity is tightly regulated and inappropriate activation is a frequent cause of cancer4-6; however, the structural basis for RAF regulation is poorly understood at present. Here we use cryo-electron microscopy to determine autoinhibited and active-state structures of full-length BRAF in complexes with MEK1 and a 14-3-3 dimer. The reconstruction reveals an inactive BRAF-MEK1 complex restrained in a cradle formed by the 14-3-3 dimer, which binds the phosphorylated S365 and S729 sites that flank the BRAF kinase domain. The BRAF cysteine-rich domain occupies a central position that stabilizes this assembly, but the adjacent RAS-binding domain is poorly ordered and peripheral. The 14-3-3 cradle maintains autoinhibition by sequestering the membrane-binding cysteine-rich domain and blocking dimerization of the BRAF kinase domain. In the active state, these inhibitory interactions are released and a single 14-3-3 dimer rearranges to bridge the C-terminal pS729 binding sites of two BRAFs, which drives the formation of an active, back-to-back BRAF dimer. Our structural snapshots provide a foundation for understanding normal RAF regulation and its mutational disruption in cancer and developmental syndromes.
Insights
Structural insights reveal how 14-3-3 proteins regulate BRAF kinase activity. These findings explain BRAF
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- RAF kinases, including BRAF, are key regulators of the MAP kinase cascade controlling cell growth.
- Dysregulated RAF activity is implicated in various cancers, yet its structural regulation remains unclear.
- Understanding BRAF regulation is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To elucidate the structural mechanisms underlying BRAF kinase autoinhibition and activation.
- To investigate the role of 14-3-3 proteins in BRAF regulation.
- To provide a structural basis for understanding BRAF mutations in cancer.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was employed to determine high-resolution structures.
- Structures of full-length BRAF were solved in complex with MEK1 and 14-3-3 dimers.
- Analysis focused on autoinhibited and active states of BRAF.
Main Results:
- An autoinhibited BRAF-MEK1 complex is stabilized by a 14-3-3 dimer binding to phosphorylated BRAF sites.
- 14-3-3 binding sequesters key BRAF domains, preventing kinase dimerization and activity.
- Activation involves 14-3-3 mediating the formation of an active, dimeric BRAF kinase.
Conclusions:
- The 14-3-3 dimer acts as a crucial scaffold, controlling BRAF kinase autoinhibition and activation.
- These structural findings offer insights into BRAF regulation and its aberrant function in disease.
- The study provides a framework for understanding BRAF-related cancers and developmental disorders.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Affects Focal Adhesions
Some...

